Use of scoring to induce reproducible drug delivery from osmotic pulsatile tablets Score-induced osmotic pulsatile drug delivery T.M. Ryan et al.

Pharmaceutical Development and Technology

Volumn 14, Issue 5, 2009, Pages 548-555

  Rahemba, Tara Ryan ^a   Bell, Samuel ^a   Connolly, Emilia K ^a   Waterman, Kenneth C ^a  

^a PFIZER INC   (United States)

Author keywords

Controlled drug delivery; Osmotic; Pulsatile

Indexed keywords

CELLULOSE ACETATE; CROSCARMELLOSE SODIUM; MACROGOL; MICROCRYSTALLINE CELLULOSE; SALICYLIC ACID; SORBITOL;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; MEMBRANE PERMEABILITY; OSMOTIC PULSATILE TABLET; PRIORITY JOURNAL; SCORING SYSTEM; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION;

ANTI-INFECTIVE AGENTS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; OSMOSIS; SALICYLIC ACID; TABLETS;

EID: 70350656249     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450902838692     Document Type: Article

References (15)

1. Maroni A, Zema L, Cerea M, Sangalli ME. Oral pulsatile drug delivery systems. Expert Opin Drug Deliv 2005;2(5):855-871.
2. Mastiholimath VS, Dandagi PM, Samata Jain S, Gadad AP, Kulkami AR. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm 2007;328(1):49-56.
3. Ishino R, Yoshino H, Hirakawa Y, Noda K. Design and preparation of pulsatile release tablet as a new oral drug delivery system. Chem Pharmaceut Bull 1992;40(11):3036-3041.
4. Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit Rev Therapeut Drug Carrier Syst 2001;18(5):433-458.
5. Mohamad A, Dashevsky A. In vitro and in vivo performance of a multiparticulate pulsatile drug delivery system. Drug Dev Ind Pharm 2007;33(2):113-119.
6. Efentakis M, Koutlis A, Vlachou M. Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled- release systems. AAPS PharmSciTech 2000;1(4): article 34.
7. Sungthongjeen S, Puttipipatkhachorn S, Paeratakul O, Dashevsky A, Bodmeier R. Development of pulsatile release tablets with swelling and rupturable layers. J Control Release 2004;95:147-159.
8. Chidlaw MB, Friesen DT, Herbig SM, Nightingale JAS, Oksanen CA, West JB. Controlled-release of an active substance into a high fat environment. EP Patent 1, 572, 163, September 14, 2005.
9. Morita R, Honda R, Takahashi Y. Develoment of oral controlled release preparations: A PVA swelling controlled release system (SCRS) I, Design of SCRS and its release controlling factor. J Control Release 2000;63(3):297-304.
10. Fan TY, Wei SL, Yan WW, Chen DB, Li J. An investigation of pulsatile release tablets with ethylceullose and Eudragit(R) L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J Control Release 2001;77(3):245-251.
11. Zhang Y, Zhang Z, Wu F. A novel pulsed-release system based on swelling and osmotic pumping mechanism. J Control Release 2003;89(1):47-55.
12. am Ende M, Miller L. Mechanistic investigation of drug release from asymmetric membrane tablets: Effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release. Pharm Res 2007;24(2):288-297.
13. USP Salicylic Acid Tablets RS: USP Dissolution Calibrator Non-Disintegrating Type. http://www/usp.org/pdf/EN/ referenceStandards/ salicylicAcidTablets.pdf (accessed 5/21/07).
14. Gibson SHM, Rowe RC, White EFT. Mechanical properties of pigmented tablet coating formulations and their resistance to cracking: I. Static mechanical measurement. Int J Pharm 1988;48:63-77.
15. Salicylic Acid; MSDS No. S0506; Mallinckrodt Baker: Phillipsburg, NJ, May 4, 2007. http://www.jtbaker.com/msds/ englishhtml/S0506.htm (accessed 07/01/07).